Weiss Multi-Strategy Advisers’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-9,000	Closed	-$560K	–	526
2014 Q4	$560K	Sell	9,000 -51,000	-85%	-$2.91M	0.02%	331
2014 Q3	$3.12M	Sell	60,000 -10,500	-15%	-$535K	0.08%	251
2014 Q2	$3.62M	Buy	+70,500	New	+$3.18M	0.08%	258
2013 Q3	–	Sell	-45,000	Closed	-$1.56M	–	1015
2013 Q2	$1.56M	Buy	+45,000	New	+$1.58M	0.05%	342

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Weiss Multi-Strategy Advisers's XBI Position: Q1 2022 in Review

Weiss Multi-Strategy Advisers sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 4,873 shares — an estimated $546K sold.

Weiss Multi-Strategy Advisers first reported a position in XBI in Q1 2014 and held it in 2 quarters. The position peaked at $10.4M in Q1 2014. 703 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

Weiss Multi-Strategy Advisers reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 4,873 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $546K.
Weiss Multi-Strategy Advisers first reported a position in State Street SPDR S&P Biotech ETF in Q1 2014 and held it in 2 quarters.
Weiss Multi-Strategy Advisers's State Street SPDR S&P Biotech ETF position peaked at $10.4M in Q1 2014.
703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2022, filed 16 May 2022.